Alle Studien
RekrutierungPhase II und Phase III (Integriert)Interventionell

Evasayil TM: A placebo-controlled trial to evaluate the efficacy and safety of spesolimab in the treatment of patients with Netherton syndrome

This research study is looking into a new medicine called spesolimab (also known by its trial code BI 655130) for people with Netherton syndrome. Netherton syndrome is a rare genetic skin condition. The study aims to find out if spesolimab is effective at treating the symptoms of Netherton syndrome and if it is safe to use. To do this, some participants will receive the active medicine, while others will receive a 'dummy' treatment called a placebo, which looks just like the real medicine but contains no active drug. Researchers will compare the groups to understand the medicine's effects. The study will measure improvements in skin symptoms, as well as how participants feel in terms of pain, itch, and their daily lives. It's an important step in finding better ways to manage Netherton syndrome.

Auf einen Blick

Status
Rekrutierung
Phase
Phase II und Phase III (Integriert)
Sponsor
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A., Boehringer Ingelheim RCV GmbH & Co. KG
Einschreibeziel
20
Starten
25. Apr 2023

Worum geht es in dieser Studie?

This study is about a new medicine called spesolimab (also known as BI 655130) for a rare skin condition called Netherton syndrome. Netherton syndrome is a lifelong condition that causes very dry, red, and flaky skin, often with severe itching and other problems. Because it's a genetic condition, people are born with it.

The main goal of this study is to see if spesolimab can make a real difference to the skin symptoms of people living with Netherton syndrome and if it is safe to use. Researchers want to find out if the medicine can reduce the severity of the skin problems by at least half. They will also be looking at other important things, like how much pain and itching people experience, how much the condition affects their daily lives, and if there are any side effects from the treatment.

To make sure the results are reliable, some participants will receive the active medicine, spesolimab, while others will get a 'placebo.' A placebo is a treatment that looks exactly like the real medicine but doesn't contain any active drug. This helps scientists compare the effects of the actual medicine against no treatment, so they can be sure any improvements are due to spesolimab and not just chance. Finding new, effective, and safe treatments could significantly improve the lives of people with Netherton syndrome.

Wichtige Erkenntnisse

  • This study is testing a new medicine (spesolimab) for Netherton syndrome.
  • It aims to see if the medicine is effective and safe for people with the condition.
  • Some participants will receive the active medicine; others will receive a placebo.
  • The study measures improvements in skin symptoms, pain, itch, and quality of life.
  • It's open to adults aged 18 and over.
  • Participation involves regular clinic visits and monitoring.

Wer könnte berechtigt sein?

To join this study, you need to be an adult, aged 18 years or older. The study is open to both men and women.

There will be other, more detailed requirements that you'd need to discuss with your doctor or the study team. These might include things like your current health, any other medicines you're taking, or how stable your Netherton syndrome is right now. These rules are in place to help make sure the study is as safe as possible for everyone involved and that the results are clear and accurate.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Sind Sie 18 Jahre alt oder älter?
  2. Do you have a diagnosis of Netherton syndrome?
  3. Are you able to travel to study appointments?
  4. Sind Sie bereit, möglicherweise ein Placebo zu erhalten?
  5. Are you currently in a stable health condition (not including your Netherton syndrome)?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

Taking part in this study means you would receive either the study medicine (spesolimab) or a placebo (dummy treatment), given as an injection or infusion. You would have regular visits to the clinic so the study team can monitor your health, check your skin, and see how you're responding to the treatment. These visits will involve various tests and assessments, such as looking at your skin, asking about your pain and itch, and how it impacts your daily life. The study will last for a period of time, which the study team will explain to you in detail. There will also be follow-up appointments after you finish taking the study medicine to make sure you're doing well.

Potenzielle Risiken und Vorteile

Participating in a study like this could offer potential benefits, such as gaining access to a new medicine before it's widely available, and helping others by contributing to scientific knowledge. However, there are also potential risks, like experiencing side effects from the medicine or having to attend frequent clinic visits. You will be closely monitored for any unwanted effects and have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Standorte (11)

Einige Standortangaben sind ungefähr. Wir arbeiten daran, dies zu verbessern — bitte überprüfen Sie die Angaben mit dem Versuchsteam, bevor Sie reisen.
  • —
    Unbestätigt
    Spanien
  • —
    Unbestätigt
    Belgien
  • —
    Unbestätigt
    Bulgarien
  • —
    Unbestätigt
    Deutschland
  • —
    Unbestätigt
    Italien
  • —
    Unbestätigt
    Finnland
  • —
    Unbestätigt
    Portugal
  • —
    Unbestätigt
    Tschechien
  • —
    Unbestätigt
    Österreich
  • —
    Unbestätigt
    Niederlande
  • —
    Unbestätigt
    Frankreich

Häufige Fragen

What is Netherton syndrome?

Netherton syndrome is a rare genetic skin condition that causes chronic red, scaly skin, severe itching, and hair abnormalities.

Was ist Spesolimab?

Spesolimab is a new medicine being tested to see if it can help improve the skin symptoms of Netherton syndrome.

Was ist ein 'Placebo'?

A placebo is a 'dummy' treatment that looks like the real medicine but contains no active drug. It helps researchers compare the effects of the actual medicine.

Werde ich wissen, ob ich das echte Medikament oder das Placebo erhalte?

Usually, in this type of study, neither you nor your doctor will know if you're getting the active medicine or the placebo until the study is over. This is called 'blinding' and helps ensure fair results.

Wie lange dauert die Studie?

The full duration of the study, including treatment and follow-up, will be explained in detail by the study team if you are interested in participating.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Evasayil TM: A placebo-controlled trial to evaluate the effi… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.